Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Arcturus Therapeutics Holdings (ARCT) Return on Capital Employed (2019 - 2025)

Arcturus Therapeutics Holdings (ARCT) has disclosed Return on Capital Employed for 7 consecutive years, with 0.32% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Capital Employed rose 1.0% year-over-year to 0.32%, compared with a TTM value of 0.32% through Dec 2025, up 1.0%, and an annual FY2025 reading of 0.28%, up 2.0% over the prior year.
  • Return on Capital Employed was 0.32% for Q4 2025 at Arcturus Therapeutics Holdings, down from 0.3% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.21% in Q1 2023 and bottomed at 0.75% in Q1 2022.
  • Average Return on Capital Employed over 5 years is 0.3%, with a median of 0.29% recorded in 2025.
  • The sharpest move saw Return on Capital Employed surged 96bps in 2023, then plummeted -61bps in 2024.
  • Year by year, Return on Capital Employed stood at 0.65% in 2021, then surged by 108bps to 0.05% in 2022, then plummeted by -535bps to 0.22% in 2023, then tumbled by -52bps to 0.33% in 2024, then increased by 3bps to 0.32% in 2025.
  • Business Quant data shows Return on Capital Employed for ARCT at 0.32% in Q4 2025, 0.3% in Q3 2025, and 0.26% in Q2 2025.